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It was hypothesized that regional myocardiai blood flow could 
be measured using myocardial contrast echocardiography. 
Accordingly, arterial blood was perfused into the coronary 
circulation in 16 dogs. In Group 1 dogs (n = S), blood flow to 
the cannulated left circmnliex artery was controlled with use 
of a roller pump, whereas in Group 2 dogs (n = 8) blood flow 
to the left anterior descending coronary artery was controlled 
by a hydraulic occluder placed around it. Sonicated micro- 
bubbles (mean size 4 pm) were used as the contrast agent. In 
Group 1 dogs the microbubbles were injected subselectively 
into the left circumiiex artery, whereas in Group 2 dogs they 
were injected selectively into the left main coronary artery and 
two-dimensional echoeardiographic images were recorded. 
Computer-generated time-intensity curves were derived from 
these images and variables of these curves correlated with 
transmural blood flow measured with radioiabeled micro- 
spheres. 
A gamma-variate function (y = Ate-“‘) best described 
the curves, and a (a variable of curve width) correlated well 
with transmurai blood flow at different flow rates in ail 
Group 1 and Group 2 dogs (mean r = 0.81 and 0.97, 
respectively). Other variables of the curve width also corre- 
lated well with myocardial blood flow, but peak intensity had 
a poor correlation with myocardial blood flow in both groups 
of dogs (r = 0.39 and r = 0.63, respectively). When data 
from all dogs were pooled, Group 1 dogs still showed good 
correlation between variables of curve width and myocardiai 
blood flow (r = 0.81); Group 2 dogs did not (r = 0.45). The 
difference between the two sets of dogs was related to the site 
of contrast agent injection. 
It is concluded that measurement of the transit time of 
microbubbles through the myocardium with two-dimen- 
sional echocardiography accurately reflects regional myocar- 
dial blood flow. Although injection of contrast agent selec- 
tively into the left main coronary artery only allows 
measurement of relative flow, it may be feasible to measure 
absolute Row by injecting contrast agent subselectively into a 
coronary artery. Myocardial contrast echocardiography 
may, therefore, offer the unique opportunity of shuulta- 
neously assessing regional myocardial perfusion and function 
in vivo. 
(J Am Co11 Cardiol1989;13:468-82) 
Currently there is no readily available technique that can 
simultaneously provide an estimation of regional myocardial 
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perfusion and function in vivo. Myocardial contrast echo- 
cardiography, which involves the intracoronary or intraaor- 
tic injection of microbubbles of air, is a new technique 
capable of defining in vivo the “area at risk” for necrosis 
after coronary occlusion (l-4). It has become an acceptable 
laboratory technique for defining the size of the perfusion 
zone of a coronary artery in vivo and changes induced in the 
perfusion zone after short-term interventions (5-10). Past 
attempts to use myocardial contrast echocardiography for 
measuring myocardial blood flow have been limited by the 
relatively large size of the microbubbles (12 to 70 pm) with 
myocardiai clearance times of 60 to 120 s, which are much 
longer than those of red blood cells (11-13). 
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Recently, smaller bubbles of the size of red cells have 
become available with use of sonication (14). The capillary 
transit time of these microbubbles has been reported to be 
similar to that of red blood cells (15,16). We, therefore, 
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hypothesized that the measurement of the transit time of 
these bubbles through the myocardium with two-dimen- 
sional echocardiography should reflect regional myocardial 
blood flow. As two-dimensional echocardiography can de- 
fine regional myocardial function (17-19), the ability to 
measure regional myocardial blood flow could add the 
simultaneous capability of assessing regional perfusion in 
vivo. This study was undertaken to determine if regional 
myocardial blood flow can be measured in different canine 
models in vivo with myocardial contrast echocardiography. 
Methods 
Animal preparation. Two groups of mongrel dogs were 
used for these experiments. Group 1 comprised eight dogs 
(mean weight ? 1 SD 26 t 4 kg) whose left circumflex 
coronary artery was cannulated and perfused with arterial 
blood withdrawn from the right carotid artery. The flow rates 
to the left circumflex artery were controlled with use of a 
roller pump. This model was meant to allow subselective 
injection of contrast agent directly into this artery. Group 2 
included eight dogs (mean weight 25 t 3 kg) whose left main 
coronary artery was cannulated with a Gregg cannula. 
Arterial blood was withdrawn from the right femoral artery 
and infused into the left main artery at a constant rate. In this 
group of dogs, blood flow to the left anterior descending 
coronary artery was controlled by a hydraulic occluder 
placed around the artery. This model was meant to allow 
selective injection of contrast agent into the left main artery 
to simulate cardiac catheterization in humans. 
All dogs were anesthetized with 30 mg/kg body weight of 
intravenous sodium pentobarbital (Abbott Laboratories), 
intubated and ventilated with a respiratory pump (model 607, 
Harvard Apparatus). Additional anesthesia was given as 
needed during the experiment. An 8F catheter was placed in 
the left femoral artery for continuous recording of arterial 
pressure and connected to an 8-channel physiologic recorder 
(model 4568C, Hewlett-Packard) by way of a fluid-filled 
transducer (model 1280C. Hewlett-Packard). In Group 2 
dogs this catheter was also used for the withdrawal of 
reference arterial blood samples during injection of radiola- 
beled microspheres into the left atrium. A similar catheter 
was placed in the left femoral vein for intravenous adminis- 
tration of fluids and drugs as needed. 
Group 1 dogs (Fig. 1). A median sternotomy was per- 
formed and the heart was suspended in a pericardial cradle. 
The midportion of the left circumflex coronary artery was 
dissected free from the surrounding tissues and two silk ties 
were placed loosely around it. The right carotid artery was 
exposed, and a 12F plastic cannula (model 1058, C.R. Bard) 
with the distal end clamped was inserted in it. This cannula 
was connected to a plastic tubing with a 0.19 in. (0.48 cm) 
internal diameter (Tygon, Norton Performance Plastics) 
whose other end was connected to a custom-designed stain- 
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Figure 1. Diagrammatic representation of the animal model used 
for Group I dogs; see text for details. 
less steel cannula. The following were connected to the 
plastic tubing (in order) along its length: 1) a stopcock on a 
Y-connector to inject radiolabeled microspheres; 2) two 
magnetic stirrers attached in series (model PC-103, Corning 
Glass Works); 3) two windkessels attached in series; 4) a 
roller pump (model 1784, Imico); 5) a stopcock on a Y- 
connector to inject the echographic contrast agent; and 6) an 
extracorporeal electromagnetic flow probe with 0.13 in. (0.32 
cm) internal diameter (model EP3OOA, Carolina Medical 
Electronics) connected to a flowmeter (model FM501, Caro- 
lina Medical Electronics) that in turn was connected to the 
physiologic recorder. 
After heparinization and administration of lidocaine (see 
Protocols), the clamp around the plastic cannula in the right 
carotid artery was removed and the roller pump started to 
prime the entire tubing with arterial blood. One of the ties 
around the middle of the left circumflex coronary artery was 
used to occlude it. The distal end of the metal cannula was 
introduced into the lumen of the artery through a small 
incision distal to the occlusion. The other tie was then placed 
around the artery to hold the tip of the cannula in place and 
the roller pump was adjusted to the desired flow rate. 
Group 2 dogs (Fig. 2). A left lateral thoracotomy was 
performed and the heart was suspended in a pericardial 
cradle. The left main and proximal left anterior descending 
and circumflex arteries were dissected free from the sur- 
rounding tissues. A silk tie was placed loosely around the left 
main artery, an appropriately sized electromagnetic flow 
probe (model EP406, Carolina Medical Electronics) was 
placed around the circumflex artery and a fluid-filled hydrau- 
lic occluder was placed around the left anterior descending 
artery. The flow probe around the circumflex artery was 
connected to a flowmeter (model FM502, Carolina Medical 
Electronics). A 22 gauge intravascular Teflon catheter (Tra- 
venal Laboratories) was inserted through the anterior wall of 
the left anterior descending artery and the tip placed in the 
lumen. This catheter was used to measure the pressure in the 
artery distal to the hydraulic occluder that was used to create 
graded coronary stenoses. A 4F catheter was inserted in the 
left atrium and secured there with a silk tie. This catheter 
was used to measure the left atrial pressure and for the 
injection of radiolabeled microspheres. Both the catheters 
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Figure 2. Diagrammatic representation of the animal model used 
for the Group 2 dogs; see text for details. A = artery; L = left; LAD 
= left anterior descending artery. 
placed in the left anterior descending artery and the left 
atrium were connected to the physiologic recorder with 
fluid-filled transducers (model 128OC, Hewlett Packard). 
The right femoral artery was exposed and a 12F cannula 
(1058, C.R. Bard), with the distal end clamped, was placed in 
it. The other end of this cannula was connected to a plastic 
tubing with 0.19 in. (0.48 cm) internal diameter (Tygon, 
Norton Performance Plastics). This tubing was placed in a 
constant-flow roller pump (Series S, Manostat) and its other 
end was connected to a short arm of a Y-connector. The 
other short arm of the Y-connector was attached to a plastic 
tubing with 0.19 in. (0.48 cm) internal diameter which in turn 
was connected to a power injector (model 3000, Liebel- 
Flarsheim). This tubing had a stopcock inserted in the 
middle to allow introduction of the contrast agent. The long 
end of the Y-connector was attached to a custom-designed 
stainless steel Gregg cannula with another piece of tubing. 
The entire system was primed with heparinized 0.9% saline 
solution, and the tip of the Gregg cannula inserted into the 
ascending aorta through an incision in the left innominate 
artery. 
After heparinization and administration of lidocaine (see 
Protocols), the clamp on the cannula placed in the femoral 
artery was removed and the roller pump started at a slow 
speed to replace the saline solution in the system with 
arterial blood. The tip of the Gregg cannula was maneuvered 
into the left main artery and secured in place with the silk tie 
placed around the left main artery. The roller pump was 
adjusted such that the left circumflex coronary artery flow 
was similar after introduction of the Gregg cannula into the 
left main artery as before its introduction. The rate of the 
roller pump was kept constant throughout the experiment. 
Acquisition 6f echocardiographic data. Two-dimensional 
echocardiographic studies in Group 1 dogs were performed 
with use of a mechanical sector scanning system with a 5 
MHz transducer and eight levels of gray (Mark-III, Ad- 
vanced Technology Laboratories). A short-axis view of the 
heart was obtained at the midpapillary muscle level. The 
depth was adjusted to allow adequate visualization of the left 
circumflex coronary artery bed. Studies in Group 2 dogs 
were performed with use of a mechanical sector scanning 
system with an 8 MHz transducer and 256 levels of gray 
(ND-256, Biosound). Short-axis images were acquired at the 
midpapillary muscle level at a depth of 4 cm so that only the 
anterior half of the heart could be visualized on the echo- 
graphic images. No time gain compensation was used. For 
both groups of dogs, the transducer was fixed at the same 
short-axis level throughout the experiment with use of a 
clamp attached to the procedure table. The control settings 
were kept constant throughout each experiment. A saline 
bath acted as an acoustic interface between the heart and 
transducer. This bath consisted of a saline-filled polyethyl- 
ene sheet mounted on a Plexiglas stage. Images were re- 
corded on videotape with a 0.5 in. (1.27 cm) VHS recorder 
(Panasonic model NV-8950). Standard limb leads were used 
to record the electrocardiogram (ECG) on the videotape. 
In Group 1 dogs, at each stage of the experiment, 5 ml of 
sonicated Renografin-76 was hand-injected as a bolus into 
the tubing through the stopcock (Fig. 1). Sonication was 
performed with a commercially available sonicator system 
(model W375, Heat Systems Ultrasonics) at 20,000 c/s for 30 
s at an energy output of 75 W to produce microbubbles of 1 
to 7 pm in size (mean 4 pm) (16). The concentration of these 
microbubbles is 500,000 2 2OO,OOO/ml. We have previously 
demonstrated the safety of this agent in humans (20). For 
Group 2 dogs the contrast agent was made by adding 5 ml of 
Albunex (Molecular Biosystems) to 10 ml of 5% human 
albumin. Each milliliter of Albunex consisted of approxi- 
mately 500 million, 4.4 pm microbubbles. These microbub- 
bles are commercially prepared by sonication and have a 
half-life of 71 months. We have previously demonstrated 
that, compared with sonicated Renografin-76, sonicated 5% 
human albumin does not change coronary blood flow and has 
minimal effects on left ventricular or systemic hemodynam- 
its (21). Three milliliters of the contrast agent was injected 
into the left main artery during each stage with the power 
injector. This amount produced optimal myocardial opacifi- 
cation in our pilot studies. Smaller amounts produced sub- 
optimal opacification, and larger doses caused attenuation of 
echographic signals. To prevent cardiac translation, the 
respirator pump was stopped just before injection of contrast 
agent and restarted after the contrast agent disappeared from 
the myocardium. 
Computer analysis of echocardiographic images. Images 
were analyzed using an off-line image analysis system (Mi- 
pron, Kontron Electronics). This system digitizes video 
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Figure 3. Echocardiograms at every 
other end-diastolic frame at the papillary 
muscle short-axis level from the time of 
injection of contrast agent into the plastic 
tubing until its disappearance from the 
myocardium in one of the Group 1 dogs. 
See text for details. 
images in real time and stores them in RAM for further 
processing. End-diastolic images, recorded just before con- 
trast injection and until its disappearance from the myocar- 
dium, were selected for analysis. In Group 1 dogs, the left 
circumflex coronary artery perfusion bed was identified by 
visualizing the images on the computer with use of a video- 
loop format. Figure 3 illustrates every other end-diastolic 
frame from the time of injection of contrast agent into the 
plastic tubing until its disappearance from the myocardium. 
It can be appreciated that contrast enhancement is first noted 
in the left circumflex bed in the fourth image and it appears 
brightest in the eighth image, after which it gradually dissi- 
pates. The image showing the brightest intensity was used to 
draw the borders of the left circumflex bed and the outlines 
of the left ventricular myocardium on an acetate sheet placed 
over the video screen. A 9 x 9 pixel region of interest was 
selected over the left circumflex bed. Care was taken not to 
include the specular-appearing endocardium and epicardium 
within this region. The acetate sheet with the region of 
interest and landmarks was placed over each end-diastolic 
frame (starting from just before injection of contrast agent 
and until its disappearance from the myocardium) and the 
average pixel intensity in each region measured. This ap- 
proach of aligning landmarks in each end-diastolic frame 
allowed reasonable data registration despite significant car- 
diac translation. 
In Group 2 dogs, the left anterior descending artery bed 
for each dog was identified during the stage when transmural 
blood flow was lowest. In almost all cases, the contrast agent 
either did not appear in the bed or poorly opacified it, making 
its borders apparent. These borders were drawn on an 
acetate sheet along with other landmarks such as the antero- 
lateral papillary muscle and the anterior left-right ventricular 
junction. This sheet was used to identify the left anterior 
descending artery bed for the other stages in the same 
experiment. It was placed on any one of the end-diastolic 
images in a stage, and the computer calculated the average 
video intensity in that region for each end-diastolic frame. 
Because the respirator had been stopped, cardiac translation 
did not occur. The mean video intensity and the frame 
number for each end-diastolic frame thus analyzed were 
automatically entered into an ASCII file, which was then 
transferred over a RS-232 interface to a minicomputer (VAX 
8200, Digital Equipment), where it was converted into a 
table in RSll (Bolt, Beraneck, and Newman), for further 
analysis. As the echographic images were obtained at a 
depth of 4 cm, the left anterior descending artery bed 
occupied a large portion of the image and varied in size from 
3,000 to 5,000 pixels. 
Derivation of contrast washout variables. The variables 
measured from the time-intensity plots derived from the 
echocardiographic images are shown in Figure 4. The inter- 
vals measured from the actual plots (in seconds) were 1) time 
from injection to appearance of contrast in the myocardium; 
2) time from appearance of contrast in the myocardium to 
peak intensity of contrast effect; 3) half-life of contrast 
medium in the myocardium; 4) time from appearance of 
contrast in the myocardium to half of maximal contrast 
effect; 5) time from appearance to disappearance of contrast 
from the myocardium; and 6) a measure of the curve width 
with use of a gamma-variate function (see later). In addition, 
the peak intensity of contrast effect in the myocardium was 
also calculated as the mean of the three highest values from 
the time-intensity plot. Before these variables were derived, 
background activity was determined from the frames pre- 
ceding contrast appearance (Fig. 3). The average back- 
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ground activity was calculated and subtracted from all 
subsequent activity. Data obtained after contrast appearance 
in the myocardium were used to fit the curve described later. 
A measure of curve width was obtained by performing a 
nonlinear least-squares curve jit with use of the following 
gamma-variate function: y = AtePort, where A is a scaling 
factor, t is time, and m is an index of curve width (22). For 
this function, the time of appearance of contrast in the 
myocardium to the peak contrast effect is l/a; the time from 
appearance of contrast to the inflection point on the down- 
slope of the time-intensity curve where the convexity turns 
concave is 2/m (Fig. 4); m is independent of the amplitude of 
the time-intensity curve, and is therefore not influenced by 
the gain settings employed during different experiments (22). 
Measurement of coronary blood flow. Blood flow to the 
left circumflex coronary artery in Group 1 dogs was mea- 
sured with the use of an extracorporeal electromagnetic flow 
probe as described previously. The flowmeter connected to 
the probe was calibrated before each experiment by petfus- 
ing 0.9% saline solution through it at five different flow rates 
obtained with the roller pump and allowing this solution to 
accumulate in a graduated cylinder over 1 min. The flow 
measured by the flowmeter and the actual flow in milliliters 
per minute measured in the graduated cylinder were then 
correlated with use of linear regression analysis. The corre- 
lation coefficient for each experiment ranged from 0.95 to 
0.99. Blood flow to the left circumflex coronary artery in 
Group 2 dogs was measured by placing a flow probe snugly 
around it. 
Measurement of myocardial blood flow. In Group 1 dogs, 
myocardial blood flow was determined at each stage of the 
experiment by injecting radiolabeled microspheres (DuPont, 
New England Nuclear) into the plastic tubing through the 
stopcock placed proximal to the magnetic stirrers (Fig. 1). 
Figure 4. A time-intensity curve 
(circles) from one of the Group 1 
dogs used in the study and the dif- 
ferent variables measured from the 
curve in that group of dogs which 
include: a = time from injection to 
appearance of contrast agent in the 
myocardium; b = time from ap- 
pearance of contrast agent in the 
myocardium to peak contrast agent 
effect; c = half-life of contrast agent 
in the myocardium; d = time from 
appearance of contrast agent in the 
myocardium to half of maximal 
contrast agent effect; e = time from 
appearance to disappearance of 
contrast agent from the myocar- 
dium; f = 2/q which is derived 
from the curve fit shown by the 
dotted line (see text for details); and 
g = peak amplitude of contrast 
agent. 
The magnetic stirrers were used to allow adequate mixing of 
the microspheres with the blood. In Group 2 dogs, myocar- 
dial blood flow was determined by injecting the micro- 
spheres into the left atrium (Fig. 2) just after initiation of 
withdrawal of arterial blood from the left femoral artery. Ten 
milliliters of arterial blood was withdrawn over 90 s with the 
use of a constant rate pump (model 644, Harvard Appara- 
tus). Approximately 2 x 106, 10 to 15 pm size microspheres 
were injected at each stage of the experiment and were 
agitated in 4 ml of 0.9% saline solution-0.010~Tween 80 
before injection (23). Microspheres for each stage were 
selected from any of the six available in the laboratory on 
that day: cerium-141 (110 to 200 keV), chromium-51 (280 to 
360 keV), tin-l 13 (362 to 440 keV), ruthenium-103 (450 to 570 
keV), niobium-95 (650 to 848 keV), and scandium-46 (850 to 
1,300 keV). The stopcock through which the microspheres 
were injected was flushed immediately after injection with 5 
ml of 0.9% saline solution. 
At the end of the experiment the animal was killed and 40 
ml of Monastral Blue solution (0.5% Monastral Blue dye, 
Sigma Chemical, in phosphate buffer solution mixed with 5% 
dextran and 0.9% saline solution) was injected into the left 
circumflex coronary artery through the metal cannula, still in 
place in the Group 1 dogs and into the left anterior descend- 
ing coronary artery in the Group 2 dogs through the distally 
positioned catheter after ligating the artery at the site of the 
hydraulic occluder. The heart was excised and the atria, 
great vessels and epicardial fat discarded. A 1 cm thick slice 
of the left ventricle was then cut corresponding to the 
short-axis slice seen on echocardiography (6). 
The area of the myocardium stained by the blue dye was 
removed and cut into wedge-shaped segments. The number 
of segments (usually three to six) depended on the size of the 
arterial bed. Each of these segments was then cut into an 
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inner, middle and outer portion. The rest of the heart was 
also cut into small pieces. All myocardial samples were 
placed in preweighed plastic tubes that were then reweighed 
in an electronic balance (model 1601, Sartorius). The sam- 
ples were counted for 500 s in a well counter with a 
multichannel analyzer (Auto-Gamma Scintillation Spectrom- 
eter model 5986, Packard Instrument). The reference blood 
sample in Group 2 dogs was also counted in a similar 
manner. The sample weights and counts were automatically 
transferred to a minicomputer (VAX 8200) with an RS-232 
interface. Activity spilling from one window to another was 
corrected with a custom-designed program. 
In Group 1 dogs, myocardial bloodflow (MBF) at each 
stage of the experiment was calculated for each sample 
within the left circumflex coronary artery perfusion bed with 
the following equation: 
MBF (mumin per g) = ( 
counts in the tissue 
x CBF)iWT, 
total counts in the entire heart 
where CBF = coronary blood flow and WT = weight of the 
tissue (23). Transmural blood flow in each segment of the 
myocardium within the left circumflex coronary artery bed 
was calculated by dividing the total flow (milliliters per 
minute) to the inner, middle and outer portions of each 
segment by the combined weight of the three portions. The 
average transmural blood flow in the left circumflex coro- 
nary artery bed was then calculated. 
In Group 2 dogs myocardial bloodflow (MBF) at each 
stage of the experiment was calculated with the following 
equation: 
MBF (ml/min per g) = 
counts in the tissue x withdrawal rate of arterial sample 
counts in the reference arterial sample 
and average transmural blood flow in the left anterior de- 
scending coronary artery bed was calculated as described 
previously (23). 
ProtoeoIs. Arterial blood gases were analyzed every hour 
in each experiment. Inhaled oxygen concentration (FIO,) 
was adjusted accordingly and sodium bicarbonate (Natcon) 
given intravenously as needed. Before cannulation of the 
coronary artery, 10,000 IU of heparin sodium (Elkins-Sinn) 
was injected intravenously followed by 2 mg/kg of lidocaine 
hydrochloride (Dexter). The latter was then infused intrave- 
nously at a rate of 1 mg/min throughout the experiment. All 
catheters were then flushed with heparinized saline solution 
and the physiologic recorder was calibrated. 
In Group 1 dogs, the roller pump was adjusted at four 
different flow rates in each experiment in random order. 
After the left circumflex coronary artery flow and aortic 
pressure were constant for 5 min, either sonicated Renogra- 
fin-76 or radiolabeled microspheres were injected in random 
order allowing a 5 min delay between injections for hemo- 
dynamic and blood flow equilibration. These steps were 
repeated for each stage of the experiment. 
In Group 2 dogs, four to six different degrees of graded 
stenosis of the left anterior descending coronary artery were 
performed in random order. After the distal left anterior 
descending artery pressure had been constant for about 5 
min, in random order either contrast agent was injected into 
the left main artery or radiolabeled microspheres were 
injected into the left atrium and arterial reference blood 
samples withdrawn from the left femoral artery. There was a 
5 min delay between microbubble and microsphere injection 
to allow for hemodynamic equilibration. These steps were 
repeated for each stage of the experiment. At the end of the 
experiment, the dog was killed and the heart prepared for 
analysis of myocardial blood flow in both groups as de- 
scribed. 
Statistical analysis. Time-intensity plots were generated 
and the gamma-variate function was fitted using RSll. All 
variables obtained from the time-intensity curves were cor- 
related with coronary blood flow and transmural blood flow 
within the left circumflex bed at each stage of the experiment 
for each dog and also for all dogs with use of linear 
regression analysis. The inverse of the curve width variable 
x was used to obtain a linear relation between m and 
coronary blood flow and a and transmural blood flow. In 
Group 1 dogs and in the four Group 2 dogs who had more 
than four time-intensity curves, a polynomial fit was per- 
formed between blood flow and peak echographic intensity. 
For determination of observer variability, two indepen- 
dent observers measured mean video intensity in the left 
anterior descending coronary artery bed in 48 different 
images according to the protocol used in Group 2 dogs. 
These observers also separately analyzed four stages from 
two different Group 2 dogs. Peak video intensity and a were 
generated from these data. A single observer then repeated 
all these observations again on a separate occasion several 
days later. Inter- and intraobserver correlations were ob- 
tained with linear regression analysis. Inter- and intraob- 
server variability was estimated with components of vari- 
ance model (BMDP:8V, Department of Biomathematics, 
University of California), and observer error was expressed 
as the square root of the variance. 
Results 
Group 1 Dogs 
A total of 24 stages (average of 3 in each dog) were 
analyzed in Group 1 dogs (Table 1). The other data were 
inadequate because of either death of the animal or cardiac 
arrhythmias. In two dogs mechanical alternans was noted at 
low flow rates that caused variation in the end-diastolic size 
of the left ventricle precluding adequate image alignment to 
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Table 1. Coronary and Myocardial Blood Flow and Contrast Washout Data From Eight Group 1 Dogs 
Dog No. CBF TMBF a b C d e f g 
61.1 1.18 1.2 4.2 8.70 12.90 27.6 0.20 83 
91.1 1.64 4.4 2.1 7.90 10.60 22.6 0.27 71 
106.4 1.71 3.8 3.3 4.65 1.95 16.6 0.35 59 
131.0 2.03 1.9 2.9 4.20 7.10 14.4 0.37 69 
1 
2 21.2 0.24 93 
24.6 0.27 122 
20.0 0.24 106 
36.6 0.16 66 
49.3 I .60 1.9 4.3 
12.2 2.14 5.4 2.9 
95.1 2.16 3.3 3.8 
16.0 0.42 22.4 11.6 
6.90 II.20 
5.80 8.70 
8.70 20.30 
42.2 0.86 4.8 2.4 8.40 10.80 22.2 0.23 79 
54.8 1.09 4.0 2.7 6.40 9.10 17.9 0.28 69 
69.5 1.40 3.0 3.4 6.90 10.30 24.0 0.23 92 
23.3 0.59 9.3 7.9 5.50 13.40 20.3 0.21 30 
23.8 0.54 13.2 7.0 5.80 12.80 18.2 0.22 48 
123.4 2.66 3.3 2.1 4.00 6.10 8.7 0.48 73 
134.9 2.24 2.5 2.1 3.30 5.40 10.3 0.52 66 
78.2 1.25 6.1 2.9 3.90 6.80 14.9 0.39 58 
38.1 0.58 8.6 7.8 5.60 13.40 20.8 0.26 44 
87.2 1.24 5.8 2.3 6.00 8.30 19.1 0.33 46 
59.9 0.94 5.6 3.7 11.20 14.90 27.2 0.19 52 
151.7 3.45 2.8 1.2 3.10 4.30 8.2 0.65 59 
191.9 4.03 2.7 1.2 4.50 5.70 11.3 0.52 80 
72.8 1.67 4.8 4.8 9.90 14.70 
97.8 1.89 4.8 3.5 6.20 9.70 
14.4 0.33 27.4 6.1 5.70 11.80 
113 
93 
52 
19.2 0.29 
23.2 0.21 
a = time from injection to appearance of contrast in the myocardium (s); b = time from appearance of contrast in the myocardium to peak intensity of contrast 
effect (s); c = half-life of contrast agent in the myocardium (s); CBF = coronary blood flow (mlimin); d = time from appearance of contrast in the myocardium 
to half of maximal contrast effect (s); e = time from appearance to disappearance of contrast effect from the myocardium (s); f = a (s-l); g = peak amplitude 
of contrast effect in the myocardium (arbitrary units): TMBF = transmural blood flow (mi/min per g). 
generate the time-intensity curves. There were problems 
associated with variable estimation in two dogs. In one, the 
gamma-variate function could not be fitted optimally to 
derive (Y because of noise in the ascending portion of the 
time-intensity plot. In another, the peak intensity could not 
be clearly defined and therefore time of contrast appearance 
to peak effect, half of maxima1 contrast effect in the myo- 
cardium, and time of contrast appearance to half of maximal 
contrast effect could not be measured. 
Comparison of contrast-derived variables and blood flow in 
the same dog. Figure 5 illustrates the data at four separate 
levels of transmural blood flow in one dog. In Figure 5A, the 
original data points are shown along with the computer-fitted 
curves at each stage. Because the gain settings in all stages 
of each experiment were held constant, the video intensity 
units demonstrate the relative change in echographic bright- 
ness between the different stages in the experiment. Note 
that the curves did not include the images before the 
appearance of contrast in the myocardium. These images 
were used to determine background activity. It can be 
appreciated that the higher the transmural blood flow, the 
narrower the time-intensity curve. It can also be seen that 
the peak video intensity decreases at the higher flow rates. 
Figure 5B illustrates the correlation between curve width (a) 
and transmural blood flow for the four rates in the same dog. 
The correlation coefficient is excellent (r = 0.96, p < 0.05, 
SEE = 0.03). A similar correlation was noted between 0~ and 
coronary blood flow. The average correlation coefficient 
between a and transmural blood flow and (Y and coronary 
blood flow for all dogs was 0.81. 
Comparison of contrast-derived variables and blood flow in 
all dogs. The relation between (Y, the index of time-intensity 
curve width, and transmural blood flow, when data from all 
eight animals were pooled, is illustrated in Figure 6A. There 
is a good linear relation between the two (r = 0.80, p < 0.01, 
SEE = 0.08). A similar relation was found between a and 
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Figure 5. A, Data from four different stages in the same Group 1 
dog (different flow rates). The gamma-variate function has been 
fitted to the data from each stage. Zero on the x axis represents time 
of injection of contrast agent. The y axis represents background 
subtracted video intensity in arbitrary units. B, Relation between a 
and transmural blood flow (TMBF) in four stages in the same dog. 
CBF = coronary blood flow. 
coronary blood flow. All the variables that, like (Y, measured 
the width of the time-intensity curve had a good correlation 
with both transmural blood flow and coronary blood flow 
(Table 2). In contrast, the peak video intensity correlated 
poorly with transmural blood flow (r = 0.39, p = 0.06, SEE 
= 21.6) (Table 2, Fig. 6B). However, when transmural blood 
flows >3 ml/min per g were excluded from analysis, the 
correlation improved significantly (r = 0.59, p < 0.01, SEE 
= 19.3). The relation also improved (r = 0.59, p < 0.01, SEE 
= 19.7) when a polynomial fit (second order) was performed 
(Fig. 6B). 
Group 2 Dogs 
A total of 34 stages (average of 4 each) were analyzed in 
Group 2 dogs (Table 3). Certain stages were not analyzed for 
the following reasons: In one animal air was inadvertently 
introduced into the myocardium during the fourth stage, 
which remained in the myocardium for a long time, making 
it difficult to analyze that and the subsequent stages. In two 
other dogs there were technical difficulties during injection 
of the contrast agent in the first stage, such that a single 
150 B 
T 
r = 0.59 (parabohc) 
. 
. 
. 
01 
0 1 2 3 4 
TRANSMURAL BLOOD FLOW (ml/min/gm) 
Figure 6. A, Relation between (Y (ALPHA) and transmural blood 
flow in all stages in all eight Group 1 dogs. The SEE of the regression 
is 0.08. B, Relation between peak video intensity and transmural 
blood Row in all Group I dogs. Both linear and parabolic relations 
are illustrated. 
bolus was not injected. In two dogs the distal left anterior 
descending coronary artery pressure was not identical be- 
tween the injection of the contrast agent and the injection of 
microspheres during a single stage. Curve fitting could not be 
performed in three dogs because there was total lack of 
contrast opacification in the left anterior descending coro- 
nary artery bed such that the time-intensity curve was flat 
(Table 3). In each case transmural blood flow was <O. 15 ml/ 
min per g. 
Comparison of contrast agent-derived variables and blood 
flow in individual dogs. There was an excellent correlation 
between the index of curve width, (Y, and all other variables 
of curve width and transmural blood flow in each of the eight 
dogs (Table 4). The average correlation coefficients for these 
variables in each of the eight dogs were also excellent (Table 
5). An example is shown in Figure 7. The individual time- 
intensity curves for five stages in the same animal are 
illustrated in Figure 7A. Figure 7B depicts the correlation 
between = and transmural blood flow in the same dog, which 
is excellent (r = 0.96, p < 0.01, SEE = 0.14). Similar 
correlations were noted in each of the other dogs (Table 5). 
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Table 2. Correlation Between Blood Flow and Contrast Variables 
in Eight Group 1 Dogs 
Variable CBF TMBF 
a Time from injection to appearance of 0.83 0.73 
contrast in the myocardium (s) 
b Time from appearance of contrast in 0.85 0.85 
the myocardium to peak intensity 
of contrast effect (s) 
C Half-life of contrast agent in the 0.64 0.58 
myocardium (s) 
d Time from appearance of contrast in 0.85 0.82 
the myocardium to half of maximal 
contrast effect (s) 
e Time from appearance to 0.76 0.73 
disappearance of contrast effect 
from the myocardium (s) 
f (I (s-1) 0.84 0.80 
g Peak amplitude of contrast effect in 0.21 0.39 
the myocardium (arbitrary units) 
Abbreviations as in Table 1. 
In contrast, the relation between transmural blood flow and 
peak contrast intensity was not good when linear regression 
analysis was used (r = 0.53, p = 0.36, SEE = 11.3, Fig. 7C), 
with a wide variation in the correlation for individual dogs 
(r = 0.23 to r= 0.99, Table 4). As a rule (except in Dog 7, 
Table 3), the correlation between blood flow and peak video 
intensity was good when the former was --< 1 .O ml/min per 
g. When blood flow exceeded this value, the correlation 
worsened significantly (except in Dog 2). When a second- 
order polynomial fit was performed, the correlation between 
transmurai blood flow and peak video intensity improved 
(r = 0.99, p = 0.01, SEE = 1.8, Fig. 70 However, more 
than three injections were analyzed in only half the dogs 
(Table 3). Therefore a polynomial fit could not be performed 
in the other half. In the four dogs in which it was performed, 
the average correlation coefficient was 0.90 with a range of 
0.66 to 0.99 (Table 5). 
Comparison of contrast-derived variables and blood flow in 
all dogs. Unlike the Group 1 dogs, when data from all eight 
Group 2 dogs were pooled, there was poor correlation 
between the index of curve width, LY, and blood flow (r = 
0.23, p = 0.20, SEE = 0.59, Fig. 8). Similar poor correlations 
were noted between blood flow and all variables derived 
from the time-intensity curves including peak video intensity 
(Table 5). When both transmural blood flow data and time- 
intensity variables were normalized to the highest value in 
each experiment, improvement in the correlation between (Y 
and blood flow was noted (r = 0.80). The correlation did not 
improve to the same degree between peak video intensity 
and blood flow (r = 0.58). 
Inter- and intraobserver variability. Table 4 depicts the 
inter- and intraobserver variability for deriving peak video 
intensity from individual images, and deriving peak video 
intensity and a from time-intensity curves generated from 
different stages of the experiments in Group 2 dogs. The 
inter- and intraobserver correlations were good and errors 
were small for all variables measured. 
Discussion 
Our study, utilizing two separate models, demonstrates 
that the transit time of microbubbles through the myocar- 
dium quantitated with two-dimensional echocardiography 
accurately reflects regional myocardial blood flow in individ- 
ual dogs. However, absolute measurement of regional myo- 
cardial blood flow was possible only in Group 1 dogs, where 
subselective injection of contrast agent was made directly 
into the left circumflex coronary artery. In Group 2 dogs, 
where graded stenosis was performed on the left anterior 
descending artery but contrast agent was injected selectively 
into the left main artery, it was possible only to measure 
relative flow. Variables that measure the width of the time- 
intensity curve derived during the transit of the microbub- 
bles through the myocardium are more likely to reflect 
myocardial blood flow than are those that measure the peak 
amplitude of the curve. These results are consistent with 
indicator-dilution principles (24). Because two-dimensional 
echocardiography is an established clinical tool for the 
evaluation of regional function (17-19), the ability to addi- 
tionally measure regional myocardial blood flow makes it a 
viable and readily available technique for the simultaneous 
assessment of regional perfusion and function in vivo. 
Width of the time-intensity curve versus its amplitude. 
Although there are several differences between Group 1 and 
2 dogs, the major difference lies in the models themselves. In 
Group 1 dogs we used a model that allowed flow to the left 
circumflex coronary artery to be controlled with a roller 
pump. All bubbles injected into the system had to pass 
through the left circumflex bed (Fig. 1). In clinical terms this 
system would simulate the subselective injection of contrast 
agent directly into a coronary artery. In such a system, as 
the bolus reaches the myocardium it will be detected on 
echocardiography as a time-intensity plot with a specific 
height and width. If blood flow is then reduced by half and 
other conditions remain the same, the bolus will pass 
through the myocardium at half the speed resulting in 
doubling of the width of the time-intensity curve. Alterna- 
tively, if the blood flow is increased to twice its original rate, 
and the rate of injection of the bolus remains the same, there 
will be greater mixing of the contrast agent and blood 
resulting in fewer microbubbles per milliliter passing through 
the myocardium. Therefore, at high flows, the peak contrast 
intensity should decrease (Fig. SA). This dilution of bubbles 
at higher flows might explain why a parabolic curve better 
fits data in Figure 6B compared with a straight line, and why 
exclusion of flows >3 mi/min per g makes the relation more 
linear. However, low peak intensities will also be noted at 
low flow rates (Fig. 6B) because of diffusion of the bubbles 
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Table 3. Myocardial Blood Flow and Contrast Agent Washout Data From Eight Group 2 Dogs 
Dog No. TMBF a b C d e f 
1 I .59 0.70 1.00 1.7 4.8 I .42 21.0 
1.36 0.80 1.10 I.9 5.5 I.27 29.0 
0.98 1.60 2.60 4.2 9.5 0.65 34.2 
0.61 1.80 2.80 4.6 9.8 0.56 25.8 
0.29 2.40 5.00 7.4 II.3 0.37 3.x 
2.15 1.90 3.40 5.3 12.0 0.49 27.3 
1.30 3.10 4.20 7.3 17.5 0.36 32.0 
1.06 3.30 4.40 7.7 17.0 0.34 28.8 
1.80 2.80 4.20 6.0 16.0 0.45 27.0 
0.14 3.60 5.90 9.5 21.5 0.28 9.8 
0.44 3.40 4.60 8.0 16.8 0.25 21.0 
0.40 4.50 7.50 12.0 17.5 0.22 20.9 
0.15 4.80 9.20 14.0 19.2 0.19 12.6 
0.79 0.80 I .20 2.00 5.3 1.20 27.0 
0.87 0.73 0.85 I .hO 5.0 I.41 29.0 
0.50 I.10 I .40 2.50 6.0 I.05 24.5 
0.39 1.32 2.70 4.00 10.0 0.72 IX.9 
0.93 0.65 1.00 I II5 4.3 1.47 25.0 
0.75 3.00 3.20 6.20 17.0 0.38 17.0 
0.52 7.00 9.50 16.5 25.5 0.14 15.0 
1.01 2.10 2.90 5.0 13.0 0.58 25.0 
0.12 * * * * * * 
0.40 4.00 6.00 I I.0 17.0 0.24 8.2 
0.54 3.00 4.80 7.8 15.0 0.32 9.0 
0.34 6.20 6.80 13.0 19.0 0.19 6.4 
0.10 * * * * * * 
0.92 0.40 0.80 I.2 3.5 2.32 40.6 
0.90 0.60 0.70 I.3 3.6 2.14 24.9 
0.45 0.80 0.90 1.7 5.0 1.60 40.0 
0.14 * * * * * * 
8 0.81 2.70 4.70 7.4 12.5 0.37 50.4 
I .46 2.30 3.80 6. I I I.2 0.43 23.7 
0.78 2.70 4.70 7.4 13.5 0.36 21.8 
0.12 4.00 6.70 10.7 18.0 0.24 15.9 
a = time from appearance of contrast in the myocardium 10 peak effect (s): b = half-life of contrast agent in the 
myocardium (s): c = time from appearance of contrast in the myocardium to half of maximal effect (s); d = time from 
appearance to disappearance of contrast from the myocardium (s): e = (Y (S-I): f = peak contrast intensity (arbitrary 
units); TMBF = transmural blood flow (ml/min per g). * = no contrast appeared in the myocardium. 
within the blood as they pass through the tubing at a slow 
rate. In any case, a direct linear relation between peak video 
intensity and myocardial blood flow should not be expected 
in this model. 
In Group I dogs, all the injected bubbles have to pass 
through the left circumflex bed. In contrast, the number of 
bubbles reaching the left anterior descending bed in Group 2 
dogs is determined by the ratio of flow between the left 
anterior descending and the left circumflex coronary arteries 
(Fig. 2). Assuming that the flows in both arteries are similar 
at baseline, then the number of microbubbles reaching the 
left anterior descending bed would be half of the total 
number introduced into the left main artery. When the flow 
in the left anterior descending artery is reduced by half, as 
the flow in the left main artery remains unchanged, the 
number of bubbles reaching the left anterior descending bed 
would be one-third of those going to the left circumflex bed. 
Therefore, with each reduction in flow, fewer bubbles enter 
the left anterior descending bed, resulting in a potential drop 
in peak intensity. Such an effect was noted in three of the 
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Table 4. Correlation Coefficients for Transmural Blood Flow Versus Contrast Agent Washout 
Variables in Each of the Eight Group 2 Dogs 
Dog No. No. of Stages a b C d e f 
1 5 0.98 0.95 0.97 0.96 0.96 0.54 
2 5 0.90 0.96 0.99 0.95 0.97 0.73 
3 3 0.75 0.85 0.83 0.99 0.92 0.99 
4 3 0.99 0.86 0.92 0.87 0.96 0.79 
5 5 0.93 0.87 0.89 0.97 0.99 0.96 
6 3 0.90 0.99 0.99 0.97 0.99 0.90 
7 3 0.88 0.85 0.99 0.99 0.98 0.44 
8 4 0.94 0.97 0.96 0.94 0.98 0.23 
a = time from appearance of contrast in the myocardium to peak contrast agent effect (s); b = half-life of contrast 
agent in the myocardium (s); c = time from appearance of contrast in the myocardium to half of maximal effect (s); 
d = time from appearance to disappearance of contrast from the myocardium (s); e = a (s-l); f = peak contrast 
intensity in the myocardium (arbitrary units). 
four dogs when transmural blood flow decreased below 
approximately 1.0 ml/min per g (Table 3). 
When transmural blood Jlow increased above 1 .O mllmin 
per g in the Group 2 dogs, peak video intensity decreased, 
except in one dog (Table 3). A possible explanation for this 
paradoxic decrease in peak video intensity at higher flows 
could be the saturation of the echographic system, which 
could result from an increase in echo signal beyond the 
dynamic range of the system. Alternatively, if the number of 
injected microbubbles is very high, attenuation of the re- 
flected sound waves occurs. At very high bubble concentra- 
tions echo backscatter is no longer directly proportional to 
the number of bubbles, but may actually decrease as the 
number continues to rise (25). Unlike sonicated renografin, 
Table 5. Correlation Coefficients for Transmural Blood Flow 
Versus Contrast Agent Washout Variables in the Eight 
Group 2 Dogs 
Average Pooled 
Variable (n = 8 dogs) (n = 31 observations) 
a Time from appearance in the 0.91 0.40 
myocardium to peak 
contrast effect (s) 
b Half-life of contrast agent in 0.93 0.44 
the myocardium (s) 
C Time from appearance of 0.94 0.44 
contrast in the 
myocardium to half of 
maximal effect (s) 
d Time from appearance to 0.96 0.32 
disappearance of contrast 
from the myocardium (s) 
e (I (s-1) 0.97 0.45 
f Peak intensity (arbitrary 0.69* 0.25 
units) 
*In the four dogs in which more than three stages of flow were analyzed 
(Dogs 1, 2, 4 and 8), polynomial regression analysis resulted in good 
correlations between peak intensity and transmural blood flow (r = 0.99, r = 
0.98, r = 0.90 and r = 0.66, respectively; mean r = 0.90). 
where the microbubble concentration is in hundreds of 
thousands per milliliter, the concentration of albumin micro- 
bubbles is in millions per milliliter. We feel that this second 
mechanism could have resulted in the decrease in peak 
intensity noted at higher blood flows. These factors should 
not significantly affect the width of the curve. 
Selective versus subselective injection. In Group 1 dogs, 
where contrast agent was subselectively injected into the left 
circumflex coronary artery, the correlation between the 
width of the curve and blood flow was close, both for 
individual dogs and for all the dogs pooled. However, in the 
Group 2 dogs, where flow was changed in the left anterior 
descending artery but the contrast agent injected selectively 
in the left main artery, although the correlation between the 
width of the curve and blood flow was excellent for individ- 
Table 6. Observer Variability for Deriving Contrast Agent 
Washout Variables in the Eight Group 2 Dogs 
Interobserver Variability 
Variable 
Mean pixel 
intensity 
No. of 
Observations 
48 frames 
Correlation 
r = 0.90 
Error 
2.22 u 
Peak 
intensity 
8 stages r = 0.83 3.55 u 
Alpha (s-‘1 8 stages r = 0.98 0.05 
Intraobserver Variability 
Mean pixel 
intensity 
48 frames r = 0.99 0.87 U 
Peak 
intensity 
8 stages r = 0.91 3.47 u 
Alpha (SK’) 8 stages r = 0.98 0.04 
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Figure 7. A, Time-intensity curves 
from five stages in one of the Group 2 
dogs. Zero on the x axis represents the 
time of appearance of the contrast in 
the myocardium. The y axis represents 
background subtracted videointensity 
in arbitrary units. B, Relation between 
a and transmural blood flow (TMPF) 
for the five stages in the same dog. C, 
Relation between peak videointensity 
and transmural blood flow in the same 
dog. Note that although a linear fit 
yields a poor relation, a second-order 
polynomial fit yields an excellent rela- 
tion. 
TIME (seconds) 
1: TMBF = 0.96 ml/min/gm, alpha = 0.65. peak intensity = 34.2 
2: TMBF = 0.61 ml/minlgm. alpha = 0.56. peak intensity = 25.6 
3: TMBF = 1.36 ml/min/gm. alpha = 1.27. peak intensity = 26.1 
4: TMBF = 1.59 mllmm/gm. alpha = 1.40, peak intensity = 21.6 
5 TMBF = 0.29 ml/minlgm, alpha = 0.37, peak intensity = 3.6 
ual dogs, it was poor when data from all dogs were pooled. 
The reasons for this disparity between the two groups of 
dogs are related to the differences in the two models used 
and can be explained by use of indicator-dilution principles. 
Consider the experiments depicted in Figure 9A (subse- 
lective injection of contrast agent into the left circumflex 
coronary artery bed). The length of the bolus of contrast 
agent at point A is mainly determined by the volume and rate 
of injection. If these are held constant between experiments, 
then the width of the input function I(F,t) will tend to vary 
inversely with flow F at point A; the slower the flow, the 
wider the input function. Consider now the sampling of the 
microbubbles at point C in the myocardium. Let H(f,t,T) be 
the probability that a microbubble entering the myocardium 
Figure 8. Correlation between a and transmural blood flow for all 
stages in the eight Group 2 dogs. 
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at time t and flow f will remain within the myocardium for 
time r. If we assume that the input function to the myocar- 
dium is I(F,t - to), where t, is the time delay for the bolus to 
reach the myocardium from the tubing and that the relation 
between echo signal and video intensity is constant for a 
given echographic system, then the echo signal from the 
Figure 9. Diagram to illustrate the differences between the two 
models used in these experiments, see text for details. 
A. INPUT WNCTlON OUTPUT FUNCTlON 
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Flow = F 
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MICROBUBBLE 
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Flow = F 
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MYOCARDIUM 
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myocardium will be the convolutional integral: JI(F,t - 
t,)H(f,t,r)dt. In these experiments as f is proportional to F, 
the latter is the only independent variable controlling curve 
width. These experiments demonstrate the feasibility of 
measuring absolute blood flow provided all other factors 
affecting flow other than F are constant. 
Now consider the experiment in Figure 9B (selective 
injection of contrast agent into the left main artery with flow 
changes occurring only in the left anterior descending 
artery). In these experiments flow F at point A is approxi- 
mately constant for individual dogs; only fat point B varies. 
Because point B samples a portion of the bolus of contrast 
agent passing the branch point, the input function at point B 
will be the same as that at point A, irrespective of the 
disparity between F and f. The differences in the curve 
widths at point C at different stages of the experiment, 
despite the same input function at point B, is due to flow 
dependence of the curve width on the myocardial transit of 
the microbubbles H(f,t,+ Therefore, the curve widths de- 
rived from two different regions of the myocardium after a 
single injection of contrast agent will reflect relative flows to 
those two regions. 
As flow in the left main artery (F) varied widely between 
dogs, the lack of correlation between curve width and blood 
flow when data from all Group 2 dogs are pooled indicates 
that the curve width is dependent not only on the myocardial 
transport function H(f,t,r), but also on the input function 
I(F,t). For the same regional myocardial blood flow in 
different dogs, the width of the time-intensity curves derived 
from the myocardial beds would vary depending on the flow 
in the left main artery. Therefore, unless flow in the left main 
artery is also constant between dogs, absolute flow cannot 
be measured in this latter model. 
Comparison with previous studies. The disparity between 
our results and those of Kemper et al. (13), who reported a 
direct linear relation between blood flow and peak video 
intensity, can be explained by the differences between the 
models and the size and concentration of bubbles used for 
the two studies. Unlike us, Kemper et al. injected the 
bubbles into the aortic root. If we assume adequate mixing of 
the microbubbles in the aortic root, the number of bubbles 
reaching a myocardial bed should be proportional to the flow 
to the bed. Because Kemper et al. used bubbles that were 
relatively large and incapable of capillary transit, it is likely 
that the total number of bubbles entrapped in the arterioles 
were related to the flow to the bed. Notwithstanding, video 
intensity should not be expected to be proportional to the 
number of bubbles trapped in the myocardium for three 
reasons: 1) because of the nonlinearity of the electronic 
conversion of the amplitude of the echo signal to video 
intensity; 2) because of the large variance in microbubble 
size (even if the total number of bubbles entrapped within 
the myocardium is related to the flow to that region, because 
the echo signal reflected from a bubble is related to the sixth 
power of its radius (26), even a few large bubbles in a region 
of relatively low flow might result in a disproportionately 
high video intensity); and 3) most commercial echographic 
systems have a limited gray scale (8 to 64) that may not have 
adequate resolution to discriminate between small alter- 
ations in peak intensity. These reasons might account for the 
lack of correlation between peak video intensity and blood 
flow noted by other investigators (3,12) using relatively large 
microbubbles. 
Clinical implications. We have previously demonstrated 
(20) that myocardial contrast echocardiography is safe in 
humans. Other investigators (27) have confirmed these find- 
ings. The potential to use myocardial contrast echocar- 
diography for qualitatively evaluating the hemodynamic 
significance of coronary stenoses (2829) and effects of 
interventions applied to increase regional myocardial blood 
flow (29,30) have also been demonstrated in humans. The 
present study suggests that such assessments could now be 
performed in a quantitative manner. 
The advantage of an index of curve width, a, over other 
variables that measure the width of the time-intensity curve 
is that it can be automatically derived with use of a com- 
puter. The lack of observer interaction might be the reason 
why both the inter- and intraobserver variability for deriving 
this variable were minimal in our study. There may be 
practical reasons why other variables of curve width might 
not be as useful. Because the tail of the time-intensity curve 
is asymptotic, the point where the curve meets the baseline 
is not clearly defined, and it may not be possible to precisely 
define the time from appearance to disappearance of contrast 
from the myocardium. The time from the injection of con- 
trast agent to its appearance in the myocardium in our Group 
1 dog experiments was influenced by our model. In the 
clinical setting it would not be useful, because this variable 
will also be mainly determined by the length and luminal 
diameter of the coronary catheter rather than the stenosis in 
the coronary artery. 
Variables that measure the rate of turnover of an intra- 
vascular tracer will truly represent changes in flow only as 
long as the volume of tissue into which they are injected 
remains constant. Although we have no data regarding 
intramyocardial blood volume, our results indicate that the 
volume of tissue probably did not change significantly in our 
experiments. This, however, does not hold true in the 
presence of vasoactive drugs such as papavarine and dipyr- 
idamole, which may significantly alter the volume of distri- 
bution of the tracer while they are changing blood flow, 
unless corrections for changes in blood volume are also 
made. We have previously demonstrated that the area under 
the curve can be used to assess regional perfusion in such 
situations without having to correct for changes in tissue 
volume (28). 
In our Group 2 dogs we used an 8 MHz transducer and a 
shallow depth setting that allowed for ideal imaging of the 
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left anterior descending artery bed. We were, therefore, able 
to generate time-intensity plots from large regions of inter- 
est. Although such an approach may not be possible in the 
clinical situation, we believe that with newer echocardio- 
graphic systems allowing acquisition and storage of digital 
images, and having large dynamic ranges, it might be possi- 
ble, in the future, to acquire high fidelity echocardiographic 
data even in humans. Computer algorithms for automatic 
detection of end-diastolic frames, image alignment and reg- 
istration, smoothing and curve fitting within minutes of 
image acquisition have already been developed in our labo- 
ratory. 
In the Group 2 dogs, the Gregg cannula was secured in 
place, preventing “spillover” of contrast agent. In the 
clinical setting, such spillover will occur almost invariably. 
However, because it will affect the number of microbubbles 
in each injection, and not the flow within the coronary 
artery, it will not influence the width of the curve, which 
might be another reason to prefer the measurement of curve 
width over peak intensity. 
Recently, it has been demonstrated that a peripheral 
injection of contrast agent can opacify the left ventricular 
cavity in both dogs and humans (31,32). It is, therefore, 
likely that a peripheral injection of contrast agent could be 
used to opacify the left ventricular myocardium as well. 
Ignoring problems such as attenuation of the myocardium by 
contrast agent in the left ventricle, and assuming that con- 
trast agent appears in the left ventricle as a bolus, because 
the length of the bolus will be greater than the transit time of 
contrast agent through the myocardium, it will not be 
possible to use standard indicator-dilution principles to 
quantitate regional perfusion. In that situation, variables 
such as myocardial clearance of contrast agent would prob- 
ably be more useful. 
Limitations of the study. The limitations relate principally 
to technical issues, some of which are common to both series 
of experiments. Although the echocardiographic estimation 
of flow was based on imaging 4 pm bubbles that readily pass 
through the capillary beds, radiolabeled microsphere flow 
calculations were based on 10 to 15 pm spheres that get 
lodged within small arterioles. Although the roller pumps 
induced “nonpulsatile” flow in the coronary arteries, we do 
not feel that this factor could have affected our results 
significantly. Finally, although we cannot be sure that 
“streaming” of contrast agent did not occur when injected 
into the left main artery of the Group 2 dogs, the wide bore 
of the Gregg cannula and its relatively large distal opening (4 
mm) make it unlikely. 
Some technical limitations were present in the first series 
of experiments but not in the second series. These include 1) 
types of contrast agents used (variable concentration versus 
standard concentration of microbubbles); 2) method of in- 
jection of the contrast agents (hand versus power injection); 
3) type of echographic system used (5 MHz transducer and 8 
levels of gray versus 8 MHz transducer and 256 levels of 
gray); 4) acquisition of echographic images (with the respi- 
rator on versus off); and 5) comparison of mean echo 
intensity with radiolabeled microsphere-derived blood flow 
(small region of interest in a vascular bed versus most of the 
bed). These reasons might explain the better average corre- 
lation between blood flow and variables that measure the 
width of the time-intensity curves in Group 2 compared with 
the Group I dogs. 
Conclusions. We have demonstrated that washout char- 
acteristics of contrast agent from within the myocardium 
measured in vivo correlate well with postmortem estima- 
tions of regional myocardial blood flow. Variables that 
measure the width of the time-intensity curve correlate best 
with myocardial blood flow. We have also previously dem- 
onstrated that myocardial contrast echocardiography is safe 
in humans (20). We believe that this technique should, in the 
future, allow simultaneous on-line measurement of regional 
myocardial perfusion and function in both the clinical and 
experimental laboratories. 
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